ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer

Cai, Zhai*; Wang, Songsheng; Zhou, Huabin; Cao, Ding南方医科大学
Translational Oncology2024-1DOI: 10.1016/j.tranon.2023.101829
9阅读
引用收藏
分享

摘要

Accumulating studies suggest that ZHX3, the member of ZHX family, is involved in a variety of biological functions such as development and differentiation. Recently, ZHX3 may also be involved in the progression of several cancer types including renal cancer, gastric cancer, liver cancer and breast cancer. However, the potential role of ZHX3 in colorectal cancer (CRC) is still unknown. In this study, we analyzed the protein levels of ZHX3 by immunohistochemistry and evaluated its relationship with the clinicopathological features and prognosis in 286 CRC patients. In vitro cell proliferation assay, plate colony formation assay and xenograft model in nude mice were applied to evaluate CRC cell proliferative ability. Our results showed that the expression of ZHX3 was significantly downregulated in CRC tissues compared with paired adjacent nontumor tissues. Furthermore, the ZHX3 expression was found to have a strong correlation with tumor size, tumor invasion depth and TNM stage. Kaplan-Meier analysis demonstrated that low ZHX3 expression was related to a poorer overall survival and disease-free survival in CRC patients. In addition, cox's proportional hazards analysis indicated that low ZHX3 expression was an independent prognostic indicator of poor prognosis. Functionally, reduced expression of ZHX3 promotes the proliferation of CRC cells both in vitro and in vivo. Conversely, overexpression of ZHX3 inhibited the growth of CRC cells, indicated that ZHX3 was significantly correlated with CRC progression. Our results indicate for the first time that ZHX3 may be a potential marker of cancer prognosis and CRC recurrence.

学科与关键词

关键词
ZHX3Colorectal cancerImmunohistochemistryRecurrencePrognosis
相关
加载中…
  • Relationship between DHX15 expression and survival in colorectal cancer
    Fan, Leqi; Guo, Xiangyu; Zhang, Jiyi; Wang, Yuji; Wang, Jinhui; Li, Ye*REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115(5): 234-240.
  • Assessing the role of IL-35 in colorectal cancer progression and prognosis
    Zeng Jin Cheng; Zhang Zhi; Li Tian Yu; Liang Yan Fang; Wang Hong Mei; Bao Jing Jing; Zhang Jun Ai; Wang Wan Dang; Xiang Wen Yu; Kong Bin; Wang Zhi Yong; Wu Bin Hua; Chen Xiao Dong; He Long; Zhang Shu; Wang Cong Yi; Xu Jun Fa*International Journal of Clinical and Experimental Pathology, 2013, 6(9): 1806-1816.被引 15
  • LINC00460 contributes to colorectal cancer cell invasion
    Ren, Weiguo*; Zhang, Xuexiu; Li, Qiang; Pu, ChibinBIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, 2023.
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Oncology
发表日期
2024-01
卷期
第 39 卷
页码
101829
DOI
10.1016/j.tranon.2023.101829
语言
ENGLISH
成果收录
SCIE

作者

  • C

    Cai, Zhai (通讯) (第一作者)

    southern med univ

  • W

    Wang, Songsheng

    southern med univ

查看全部 4 位作者收起作者
  • Z

    Zhou, Huabin

    southern med univ

  • C

    Cao, Ding

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417